Efficacy of icotinib in advanced lung squamous cell carcinoma

BACKGROUND: There are controversial data supporting the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with advanced lung squamous cell carcinoma (SCC). In this study, the efficacy of icotinib in unselected and EGFR‐mutated patients with lung SCC wa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Liang, Shuai, Xu, Yan, Tan, Fenlai, Ding, Lieming, Ma, Yongbin, Wang, Mengzhao
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143949/
https://ncbi.nlm.nih.gov/pubmed/30109777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1736
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky